Intelligencia.ai

Intelligencia AI Solutions is a leading AI-powered platform for drug development, offering a portfolio of SaaS products that de-risk and accelerate clinical development through data-driven insights, risk assessment, and transparentAI-driven decision support. The platform focuses on increasing the probability of success across therapeutic areas by providing actionable, harmonized data and advanced analytics to inform portfolio strategy, trial design, and regulatory considerations.

---

Overview

• Purpose-built AI for pharmaceutical R&D aiming to improve decision quality and reduce development risk.
• Delivers probability-of-success estimates, risk drivers, and PTRS (Predicted Time-to-Risk/Probability of Success) assessments across the clinical development lifecycle.
• Emphasizes transparency and explainability to avoid the AI black box, showing the features and drivers behind predictions.
• Real-time program tracking with ontologies and curated data, trusted by leading pharma organizations.

---

How It Works

1. Data and Curation: Real-time tracking of clinical programs with proprietary ontologies and rigorous biomedical data curation performed by experts.
2. AI-Driven Assessments: Advanced algorithms generate PTRS-like predictions, risk scores, and drivers for technical and regulatory risks.
3. Decision Support: Outputs inform portfolio strategies, competitive landscape assessments, and optimization of clinical trial design.
4. Transparency: The platform provides visibility into model inputs and drivers to explain the how and why behind results.

---

Use Cases

• Measure the likelihood of drug development success across multiple therapeutic areas.
• Identify and quantify internal and external risks within a development portfolio.
• Detect predictive signals to optimize trial design and decision-making.
• Benchmark and monitor competitive landscapes for acquisition, licensing, and portfolio strategies.
• Standardize risk evaluation processes across entire portfolios with a single, quality-controlled data source.

---

Safety and Confidence

• Emphasizes explainable AI to foster trust and enable stakeholders to understand model rationale.
• Real-world performance tracking with high prospective accuracy and retrospective validation across development stages.

---

Core Features

• AI-driven risk and probability of success assessments for drug development
• PTRS-style metrics with high prospective accuracy (>80%)
• Real-time program tracking across therapeutic areas
• Harmonized, curated biomedical data (ontology-enabled)
• Explainable AI with transparent drivers and feature importance
• Portfolio and competitive landscape analysis for licensing and acquisitions
• Standardized risk evaluation across entire drug development portfolios
• Trusted by top global pharma companies for data-driven decision making